-
My Account
In App
My Account
BSE Live
Sep 12, 16:00Prev. Close
38.00
Open Price
38.00
Bid Price (Qty.)
38.00 (1720)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 12, 15:42Prev. Close
38.00
Open Price
38.00
Bid Price (Qty.)
38.00 (500)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Elder Pharmaceuticals (in Rs. Cr.) | Jun 14 | Jun 13 | Mar 12 | Mar 11 | Mar 10 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 1.33 | 40.12 | 35.18 | 32.55 | 26.21 | |
| Diluted EPS (Rs.) | 1.33 | 40.12 | 35.18 | 32.55 | 26.21 | |
| Cash EPS (Rs.) | 14.39 | 61.49 | 51.66 | 44.87 | 34.10 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 376.02 | 374.04 | 340.65 | 308.13 | 259.90 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 376.02 | 374.04 | 340.65 | 308.13 | 259.90 | |
| Revenue from Operations/Share (Rs.) | 490.56 | 798.24 | 649.01 | 469.35 | 382.06 | |
| PBDIT/Share (Rs.) | -26.03 | 148.80 | 109.67 | 87.12 | 67.09 | |
| PBIT/Share (Rs.) | -43.59 | 127.37 | 93.15 | 73.15 | 57.99 | |
| PBT/Share (Rs.) | 2.91 | 50.72 | 44.49 | 39.10 | 29.92 | |
| Net Profit/Share (Rs.) | -3.18 | 40.06 | 35.13 | 30.90 | 25.00 | |
| NP After MI And SOA / Share (Rs.) | -3.18 | 40.06 | 35.13 | 31.23 | 26.21 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | -5.30 | 18.64 | 16.89 | 18.56 | 17.56 | |
| PBIT Margin (%) | -8.88 | 15.95 | 14.35 | 15.58 | 15.17 | |
| PBT Margin (%) | 0.59 | 6.35 | 6.85 | 8.32 | 7.83 | |
| Net Profit Margin (%) | -0.64 | 5.01 | 5.41 | 6.58 | 6.54 | |
| NP After MI And SOA Margin (%) | -0.64 | 5.01 | 5.41 | 6.65 | 6.85 | |
| Return on Networth/Equity (%) | -0.84 | 10.71 | 10.31 | 10.18 | 10.30 | |
| Return on Capital Employed (%) | -0.50 | 5.51 | 5.54 | 5.53 | 5.17 | |
| Return on Assets (%) | -0.28 | 3.30 | 3.61 | 3.68 | 4.11 | |
| Total Debt/Equity (X) | 0.97 | 1.49 | 1.40 | 1.32 | 1.17 | |
| Asset Turnover Ratio (%) | 44.09 | 65.86 | 66.74 | 55.42 | 60.02 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.92 | 0.88 | 1.26 | 1.43 | 2.32 | |
| Quick Ratio (X) | 0.80 | 0.63 | 0.84 | 1.01 | 1.74 | |
| Inventory Turnover Ratio (X) | 7.88 | 6.70 | 4.56 | 3.99 | 5.03 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 11.42 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 8.48 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 88.58 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 91.52 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | -0.33 | 1.69 | 1.89 | 2.30 | 2.07 | |
| Interest Coverage Ratios (Post Tax) (%) | -0.33 | 1.69 | 1.89 | 2.30 | 2.07 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 654.38 | 1,714.38 | 1,519.62 | 1,370.39 | 1,170.96 | |
| EV/Net Operating Revenue (X) | 0.65 | 1.04 | 1.14 | 1.42 | 1.62 | |
| EV/EBITDA (X) | -12.22 | 5.60 | 6.74 | 7.65 | 9.24 | |
| MarketCap/Net Operating Revenue (X) | 0.44 | 0.41 | 0.52 | 0.83 | 0.94 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 88.57 | |
| Price/BV (X) | 0.58 | 0.87 | 0.99 | 1.27 | 1.41 | |
| Price/Net Operating Revenue | 0.44 | 0.41 | 0.52 | 0.83 | 0.94 | |
| Earnings Yield | -0.01 | 0.12 | 0.10 | 0.08 | 0.07 |
